Management of Stable Angina with Ivabradine as Safe Alternative to Patients with Myasthenia Gravis

  • Ohde Dalledone G
  • Lenci Marques G
  • Dal-Prá Ducci R
  • et al.
N/ACitations
Citations of this article
5Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Management of cardiac symptoms in myasthenia gravis (MG) patients can be challenging. The aim of this report is to describe the safe use of ivabradine for stable angina in MG patients. A 48 y.o. woman, with MG diagnosis, presented stable angina. Therapies choices were reduced considering concomitant disease as well as previous and unsuccessful cardiologic managements. Ivabradine showed unexpected results. The patient presented an improvement of neurological and cardiac symptoms, bringing ivabradine as one more therapeutic option to similar patients. In this report we recommend ivabradine as an effective and safe drug for treatment of stable angina in MG patients.

Cite

CITATION STYLE

APA

Ohde Dalledone, G., Lenci Marques, G., Dal-Prá Ducci, R., Laffitte Stier Junior, A., Kay, C. S. K., Cesar Werneck, L., … Herminia Scola, R. (2016). Management of Stable Angina with Ivabradine as Safe Alternative to Patients with Myasthenia Gravis. Case Reports in Neurological Medicine, 2016, 1–3. https://doi.org/10.1155/2016/3589204

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free